Catalytic Asymmetric Aza‐[2+2] Cyclization Reaction of Simple Ketoimine
Angewandte Chemie International Edition · 22.12.2025 · 64 (52)
DOI: 10.1002/anie.202518427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 22.10.2025. Verfasst von Linqing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Research Unit of Peptide Science with Chinese A…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: NFSC, Innovation Fund for Medical Sciences, Funds for Fundamental Research of Gansu Province.
Abstract (Originalsprache)
Herein, we report the first catalytic enantioselective aza‐[2+2] cyclization of simple ketoimines, thereby addressing a persistent challenge in four‐membered aza‐ring construction. While the aza‐[2+2] cyclization represents the most straightforward approach to azetidine synthesis, previous methodologies have been strictly limited to ketoimines, all with an EWG at the central reactive carbon, and predominantly employing cyclic imine substrates. Through rational design of an in situ‐generated magnesium catalytic system and systematic investigation of imine electronic effects, we have successfully developed an asymmetric protocol for simple ketoimines. This breakthrough enables efficient access to enantioenriched monocyclic azetidines with excellent stereocontrol. Moreover, a streamlined one‐pot tandem oxidation readily converts these azetidines into valuable quaternary chiral β‐lactams—privileged scaffolds that are prominent in numerous pharmaceuticals and bioactive agents. A combination of comparative studies, the calculation results of the HOMO and LUMO energies of different imines, relative control experiments, and a series of detailed NLE analysis revealed the coordination difference and the catalytic cycle. The catalytic protocol was used for the synthesis of a series of β‐lactams containing aryl or alkyl groups, as well as for pharmaceutical active molecules’ β‐lactam‐modifications. Importantly, the preliminary attempt to take advantage of the significant ring strain of β‐lactam for peptide modifications was also achieved on tryptophan.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Science, Research Unit of Peptide Science with Chinese Academy of Medical Sciences (2019RU066), Lanzhou University, Lanzhou, C…
- School of Sciences, Great Bay University, Dongguan, China.
ORCID-Profile: Dongxu Yang
Förderung
- NFSC
- Innovation Fund for Medical Sciences
- Funds for Fundamental Research of Gansu Province
- Guangdong Basic and Applied Basic Research Foundation
- Guangdong Provincial Key Laboratory of Mathematical and Neural Dynamical Systems
- Fundamental Research Funds for the Central Universities
- LongYuan Young Talents Program
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wang, L., Gao, F., Li, S., Zhang, X., Lv, J., Zhao, T., Xu, S., Wang, R., & Yang, D. (2025). Catalytic Asymmetric Aza‐[2+2] Cyclization Reaction of Simple Ketoimine. Angewandte Chemie International Edition, 64(52). https://doi.org/10.1002/anie.202518427
Vancouver
Wang L, Gao F, Li S, Zhang X, Lv J, Zhao T, et al. Catalytic Asymmetric Aza‐[2+2] Cyclization Reaction of Simple Ketoimine. Angewandte Chemie International Edition. 2025;64(52). doi:10.1002/anie.202518427
BibTeX
@article{Wang2025,
author = {Wang, Linqing and Gao, Feiyun and Li, Shixin and Zhang, Xiaoyong and Lv, Jiaming and Zhao, Tianyi and Xu, Shuyang and Wang, Rui and Yang, Dongxu},
title = {Catalytic Asymmetric Aza‐[2+2] Cyclization Reaction of Simple Ketoimine},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {52},
doi = {10.1002/anie.202518427}
}
EUVIMED